Market Tracker

10/24 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

4.37
Data as of Oct 24
 -0.08 / -1.80%
Today’s Change
2.97
Today|||52-Week Range
7.56
-23.87%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.45
Today’s open4.43
Day’s range4.30 - 4.50
Volume50,702
Average volume (3 months)166,741
Market cap$82.6M
Dividend yield--
Data as of 3:58pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-22.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.05

Competitors

 Today’s
change
Today’s
% change
LPDXLipoScience Inc-0.03-0.57%
CGIXCancer Genetics Inc-0.08-0.99%
PANGPanacea Global Inc-0.01-1.85%
GALTGalectin Therapeutic...+0.35+7.38%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts